C. Richard Piazza has been appointed chief executive officer of Chemokine Therapeutics Corp. Mr. Piazza succeeds Dr. Hassan Salari who held the position since he founded the company in 1998. Dr. Salari will continue to serve as president and his role will be expanded to include the additional responsibilities as the chief scientific officer. These changes will allow Dr. Salari to focus on the company's product development while Mr. Piazza will use his financial and biotechnology industry experience to drive corporate initiatives.
Mr. Piazza has been a member of the board of directors for since June 2001 and is currently the chairman of the board. Mr. Piazza has more than 35 years of experience managing both public and VC-backed healthcare companies. He is currently managing director of Healthios, a healthcare merchant banking firm. He has served in numerous chief executive positions including MAXIA Pharmaceuticals, VitaGen Inc., Marquest, Smith & Nephew SoloPak, Stimetics and Biolectron.